Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-03-02 | 2023-06-06 | 186061 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-02-14 | 2023-03-28 | 184632 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2022-11-11 | 2023-03-30 | 174390 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2022-09-21 | 2022-10-20 | 169691 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AVAPRO | 300MG | TABLET | Resolved | 2022-08-02 | 2022-09-17 | 165911 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVAPRO | 150MG | TABLET | Resolved | 2022-01-21 | 2022-06-09 | 153358 |
| AVAPRO | 75MG | TABLET | Resolved | 2021-12-16 | 2022-08-20 | 151325 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2021-12-08 | 2023-06-09 | 150725 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 |